Genetic polymorphism of vitamin K epoxide reductase (VKORC1) 1173C>T in a Chinese and a Caucasian population

Basic and Clinical Pharmacology and Toxicology

Volumn 98, Issue 6, 2006, Pages 611-613

  Larramendy Gozalo, Claire ^a   Yang, Jue Quin ^b   Verstuyft, Céline ^a   Bodin, Laurent ^c   Dubert, Liliane ^d   Zhang, Yong ^b   Xu, Chundi ^e   Fan, Lian ^b   Jaillon, Patrice ^d   Becquemont, Laurent ^a  

^a BICÊTRE HOSPITAL   (France)

^b SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^c INSERM   (France)

^d SORBONNE UNIVERSITÉ   (France)

^e SHANGHAI SECOND MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ACENOCOUMAROL; ANTICOAGULANT AGENT; CYTOSINE; MENADIONE EPOXIDE REDUCTASE; OXIDOREDUCTASE; THYMINE; UNCLASSIFIED DRUG; WARFARIN;

ADULT; ARTICLE; BLEEDING; CAUCASIAN; CHILD; CHINESE; CONTROLLED STUDY; DOSE CALCULATION; DRUG RESPONSE; DRUG SENSITIVITY; ETHNIC DIFFERENCE; GENE; GENE FREQUENCY; GENETIC POLYMORPHISM; GENOTYPE; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; INTERNATIONAL NORMALIZED RATIO; MAJOR CLINICAL STUDY; NUCLEOTIDE SEQUENCE; PHARMACOGENETICS; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; THROMBOEMBOLISM; VKORC1 GENE;

ADULT; ASIAN CONTINENTAL ANCESTRY GROUP; CHILD; CHINA; EUROPEAN CONTINENTAL ANCESTRY GROUP; GENE FREQUENCY; GENOTYPE; HUMANS; INTERNATIONAL NORMALIZED RATIO; MIXED FUNCTION OXYGENASES; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 33646727818     PISSN: 17427835     EISSN: 17427843     Source Type: Journal    
DOI: 10.1111/j.1742-7843.2006.pto_440.x     Document Type: Article

References (12)

1. Bodin L. C. Verstuyft D. A. Tregouet A. Robert L. Dubert C. Funck-Brentano P. Jaillon P. Beaune P. Laurent-Puig L. Becquemont M.-A. Loriot : Cytochrome P450 2C9 (CYP2C9) and vitamin K epoxide reductase (VKORC1) genotypes as determinants of acenocoumarol sensitivity. Blood 2005, 106, 135 140.
2. D'Andrea G. R. L. D'Ambrosio P. Di Perna M. Chetta R. Santacroce V. Brancaccio E. Grandone M. Margaglione : A polymorphism in the VKORC1 gene is associated with an interindividual variability in the dose-anticoagulant effect of warfarin. Blood 2005, 105, 645 649.
3. Hosking L. S. Lumsden L. K. Lewis A. Yeo L. McCarthy A. Bansal J. Riley I. Purvis C. Xu : Detection of genotyping errors by Hardy-Weinberg equilibrium testing. Eur. J. Hum. Genet. 2004, 12, 395 399.
4. Morin S. L. Bodin, M.-A. Loriot H. Thijssen A. Robert S. Strabach C. Verstuyft D. A. Tregouet L. Dubert P. Laurent-Puig C. Funck-Brentano P. Jaillon P. Beaune L. Becquemont : Pharmacogenetics of acenocoumarol pharmacodynamics. Clin. Pharmacol. Therap. 2004, 75, 403 414.
5. Rieder M. J. A. P. Reiner B. F. Gage D. A. Nickerson C. D. Eby H. L. McLeod D. K. Blough K. E. Thummel D. L. Veenstra A. E. Rettie : Effect of VKORC1 haplotypes on transcriptionnal regulation and warfarin dose. New Engl. J. Med. 2005, 352, 2285 2293.
6. Rost S. A. Fregin V. Ivaskevicius E. Conzelmann K. Hörtnagel H. J. Pelz K. Lappegard E. Seifried I. Scharrer E. G. D. Tuddenham C. R. Müller T. M. Strom J. Oldenburg : Mutations in VKORC1 cause warfarin resistance and multiple coagulation factor deficiency type 2. Nature 2004, 427, 537 541.
7. Takahashi H. G. R. Wilkinson Y. Caraco M. Muszkat R. B. Kim T. Kashima S. Kimura H. Echizen : Population differences in S-warfarin metabolism between CYP2C9 genotype-matched Caucasian and Japanese patients. Clin. Pharmacol. Therap. 2003, 73, 253 263.
8. Weibert R. T. L. A. Palinkas : Differences in warfarin dose requirements between Asian and Caucasian patients. Clin. Pharmacol. Therap. 1991, 49, 151.
9. Yang J. Q. S. Morin C. Verstuyft L. A. Fan Y. Zhang C. D. Xu V. Barbu P. Jaillon L. Becquemont : Frequency of cytochrome P450 2C9 allelic variants in the Chinese and French populations. Fund. Clin. Pharmacol. 2003, 17, 373 376.
10. Yu H. C. T. Y. Chan J. A. Critchley K. S. Woo : Factors determining the maintenance dose of warfarin in Chinese patients. QJM-Int. J. Med. 1996, 89, 127 35.
11. Yuan H. S. J. J. Chen M. T. M.Lee J. C. Wung Y. F. Chen M. J. Charng M. J. Lu C. R. Hung C. Y. Wei C. H. Chen J. Y. Wu Y. T. Chen : A novel functionnal VKORC1 promoter polymorphism is associated with inter-individual and inter-ethnic differences in warfarin sensitivity. Hum. Mol. Genet. 2005, 14, 1745 1751.
12. Zhao F. C. Loke S. C. Rankin J. Y. Guo H. S. Lee T. S. Wu T. Tan T. C. Liu W. L. Lu Y. T. Lim Q. Zhang B. C. Goh S. C. Lee : Novel CYP2C9 genetic variants in Asian subjects and their influence on maintenance warfarin dose. Clin. Pharmacol. Therap. 2004, 76, 210 219.